Trial Profile
A prospective study evaluating the efficacy and safety of Cilostazol and Bepridil combination therapy in patients with ventricular fibrillation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Bepridil (Primary) ; Cilostazol (Primary)
- Indications Ventricular fibrillation
- Focus Therapeutic Use
- 04 Dec 2015 New trial record